Kenneth J. Hillan - 07 Dec 2023 Form 4 Insider Report for Zymeworks Inc. (ZYME)

Role
Director
Signature
/s/ Daniel Dex, Attorney-in-Fact
Issuer symbol
ZYME
Transactions as of
07 Dec 2023
Net transactions value
$0
Form type
4
Filing time
08 Dec 2023, 17:17:20 UTC
Previous filing
07 Jun 2023
Next filing
06 Jun 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZYME Stock Option (Right to Buy) Award $0 +37,000 $0.000000 37,000 07 Dec 2023 Common Stock 37,000 $9.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options vest on date of next annual general meeting following grant date of December 7, 2023.